Nancy L. Cantor, Ph.D.

Neuropsychologist, Primary Children's Hospital
Adjunct Associate Professor, Department of Psychology, University of Utah

81 N Mario Capecchi Drive
Salt Lake City, UT 84113
contact address

Biosketch:

Dr. Cantor has been a psychologist at Primary Children’s Hospital since 1980. She has specialized in working with children with chronic medical problems, which has included conducting neuropsychological testing, consulting in several multidisciplinary pediatric subspecialty clinics, providing individual therapy, and conducting consultations with patients hospitalized on the inpatient medical/surgical units. She has been a psychological examiner for numerous research projects and served as Clinical Director of the Pediatric Behavioral Health Clinic from 2008-2016.

Selected Bibliography:

Payne JM, Barton B, Ullrich NJ, Cantor A, Hearps SJ, Cutter G, Rosser T, Walsh KS, Gioia GA, Wolters PL, Tonsgard J, Schorry E, Viskochil D, Klesse L, Fisher M, Gutmann DH, Silva AJ, Hunter SJ, Rey-Casserly C, Cantor NL, Byars AW, Stavinoha PL, Ackerson JD, Armstrong CL, Isenberg J, O'Neil SH, Packer RJ, Korf B, Acosta MT, North KN.
Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.
Neurology. 2016;87(24):2575-2584. PubMed abstract / Full Text

Kaleita TA, Tubergen DG, Stehbens JA, MacLean WE, Nol RB, Cherlow JM, Cantor NL, Chang PN, O’Brien RT, Ruymann F.B, Sather HN, Schwartz E, Whitt JK, Waskerwitz MJ, Hammond GD.
Longitudinal study of cognitive, motor, and behavioral functioning in children diagnoses with acute lymphoblastic leukemia: A report of early findings from the Children’s Cancer Group.
In T. Büchner et al. (Eds.) Acute leukemias VI, prognostic factors and treatment strategies. 1997; 660-673. Berlin, Heidelberg: Springer-Verlag

Stehbens JA, MacLean WE, Kaleita TA, Noll RB, Schwartz E, Cantor NL, Woodard A, Whitt JK, Waskerwitz MJ, Ruymann FB, Hammond GD.
Effects of CNS prophylaxis on the neuropsychological performance of children with acute lymphoblastic leukemia: Nine months postdiagnosis.
Children's Health Care. 1994;23:231-50.